首页> 外文期刊>Dermatology Online Journal >Targetoid lesions in a patient with systemic lupuserythematosus
【24h】

Targetoid lesions in a patient with systemic lupuserythematosus

机译:靶标毒性病变在患有全身性狼疮红斑狼疮的患者

获取原文
           

摘要

Rowell Syndrome is a rare presentation of lupuserythematosus manifesting as an eruption oferythema multiforme-like papules and plaques withimmunological findings of positive rheumatoidfactor, speckled antinuclear antibodies, and/or antiRo/La antibodies. This case highlights the unusualand highly debated presentation of RowellSyndrome in a 66-year-old woman with newlyappearing erythematous, targetoid plaques in thesetting of previously diagnosed systemic lupuserythematosus. Skin biopsy revealed histologicalfeatures of full-thickness epidermal necrosis withfocal sub-epidermal separation and a superficialperivascular lymphocytic infiltrate interpreted tofavor Rowell Syndrome given her clinical history andpresentation. Although no standard treatment exists,a prednisone taper and topical corticosteroidsproved effective initially, with complete resolution atsix months on mycophenolate mofetil andbelimumab.
机译:Rowell Syndrome是LupuseryThematosus的罕见介绍,表现为斑疹斑疹的斑疹样丘疹和斑块的斑疹症,斑点抗核抗体和/或抗炎症和/或antiroTro / La抗体。这种情况突出了非兽医在一名66岁女性中对Rowellsyndrome的高度争议介绍,其中包含新的红绿性,靶标斑块在依照以前诊断的全身性山血管术中。皮肤活检显示全厚表皮坏死的组织类细胞,鉴于她临床历史和古代历史,卓越的患者淋巴细胞浸润术治疗卓越的Rowell综合征。虽然没有任何标准治疗存在,但最初存在泼尼松锥度和局部皮质类固醇剂,但在霉酚酸酯MoFetil和Belimumab上完全分辨率。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号